Carr Edwardinsider trades
In SEC Form 4 filings, Carr Edward is listed as CHIEF ACCOUNTING OFFICER of Dianthus Therapeutics, Inc. /DE/ (DNTH). In the last 90 days, Carr Edward sold $2.03M of Dianthus Therapeutics, Inc. /DE/ (DNTH) on the open market and bought none. All 5 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| DNTHDianthus Therapeutics, Inc. /DE/ | CHIEF ACCOUNTING OFFICER | 7 | Sep 18 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-18
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| DNTHDianthus Therapeutics, Inc. /DE/ | Sep 17 | Sep 18 | M | 20,000 | $17.88 | $357,600 | 20,000 | Yes | Form 4 |
| DNTHDianthus Therapeutics, Inc. /DE/ | Sep 17 | Sep 18 | S | 7,928 | $100.43 | Sale −$796,209 | 12,072 | Yes | Form 4 |
| DNTHDianthus Therapeutics, Inc. /DE/ | Sep 17 | Sep 18 | S | 6,771 | $101.37 | Sale −$686,376 | 5,301 | Yes | Form 4 |
| DNTHDianthus Therapeutics, Inc. /DE/ | Sep 17 | Sep 18 | S | 3,501 | $102.39 | Sale −$358,467 | 1,800 | Yes | Form 4 |
| DNTHDianthus Therapeutics, Inc. /DE/ | Sep 17 | Sep 18 | S | 1,100 | $103.20 | Sale −$113,520 | 700 | Yes | Form 4 |
| DNTHDianthus Therapeutics, Inc. /DE/ | Sep 17 | Sep 18 | S | 700 | $104.39 | Sale −$73,073 | not reported | Yes | Form 4 |
| DNTHDianthus Therapeutics, Inc. /DE/ | Sep 17 | Sep 18 | M · derivative | 20,000 | $17.88 | $357,600 | 43,818 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.